USPTO serial 79406951
LEOPARD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAYS, CANDACE W
- Law office
- TMO LAW OFFICE 110
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LEOPARD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compositions and materials for use in science, in particular diagnostic reagents, other than for medical use, for sale in kit form; diagnostic kits comprising reagents for testing in agriculture; diagnostic kits comprising reagents for testing for selected environmental components; chemical testing kits for determining water properties; chemical, biological and molecular biological test kits for environmental analysis; reagents for use in environmental and agricultural analysis and testing. | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations; medical diagnostics; diagnostic preparations and materials; radio-isotope markers for therapeutic or diagnostic use; reagents, solutions and test strips for medical and veterinary purposes; diagnostic testing materials for medical use; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use; medical diagnostic test strips; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for veterinary purposes; diagnostic substances for medical use; diagnostic agents for medical use; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic reagents for medicinal use; antiserums for diagnostic purposes; reactants for medical diagnosis; indicators for medical diagnosis; reactants for veterinary diagnosis; clinical diagnostic reagents; radioactive preparations veterinary diagnosis; veterinary diagnostic reagents; diagnostic test kits for medical and veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; diagnostic strips for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for use in diagnostic tests for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; preparations for use in the diagnosis of pregnancy; in vitro diagnostic preparations for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical and veterinary use; reagents for use in diagnostic pregnancy tests. | ACTIVE | — |
| 042 | Research and development in the field of diagnostic preparations; design and development of diagnostic apparatus; environmental testing and inspection services; testing services in agriculture; agricultural diagnostic testing services. | ACTIVE | — |
| 044 | Medical services; medical and veterinary diagnostics; consultancy in the field of diagnostic medicine; genetic testing of humans or animals for diagnostic or treatment purposes; surgical diagnostic services; medical diagnostic services; performing diagnosis of diseases; optical imaging services for medical diagnostic use; medical testing for diagnostic or treatment purposes; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical services for the diagnosis of conditions of the human body; medical analysis services for diagnostic and treatment purposes provided by medical laboratories. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 18, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 18, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 16, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 16, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 18, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 18, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 22, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 25, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |